Latest news with #ThomasLogan
Business Wire
31-07-2025
- Business
- Business Wire
Mirion Announces Second Quarter 2025 Financial Results and Updates Full Year Guidance
ATLANTA--(BUSINESS WIRE)--Mirion ('we' or the 'company') (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the second quarter ended June 30, 2025. 'Our second quarter results demonstrate continued progress towards key 2025 financial targets and positively position us to capture robust market dynamics,' commented Mirion's Chairman and Chief Executive Officer Thomas Logan. 'Nuclear power and cancer care tailwinds remain vibrant and Mirion is better positioned than ever to capitalize on these favorable market trends. We improved our strategic positioning and operating performance while successfully minimizing our tariff exposure to date.' Logan continued, 'Meanwhile, we continue to strategically improve our business. In the second quarter, we successfully completed a $400 million convertible notes offering and refinanced our Term Loan B to further optimize our capital structure. Additionally, we announced the acquisition of Certrec to expand our services and software offerings. Certrec complements our existing nuclear power product suite while creating additional opportunities in the broader energy power markets. Together with Certrec, Mirion is a leading supplier to the nuclear power renaissance underway.' 2025 Guidance Commenting on Mirion's full year 2025 guidance, Logan said, 'Our first half performance, foreign exchange tailwinds, and visibility for the remainder of the year give us the confidence to increase key components of our annual guidance. Notably, capital structure enhancements contributed to our increased Adjusted Free Cash Flow and Adjusted EPS guidance.' Mirion has increased its 2025 total Revenue growth, Adjusted EBITDA (while tightening the corresponding Adjusted EBITDA margin range), Adjusted Free Cash Flow, and Adjusted EPS guidance while revising Organic Revenue growth guidance for the fiscal year ending December 31, 2025, including estimated tariff impacts based on today's levels, net of mitigating actions and updated full year foreign exchange rates. Revenue growth of approximately 7.0% – 9.0% (previously 5.0% – 7.0%); includes a foreign exchange rate tailwind of approximately 125 basis points using a Euro-to-USD exchange rate of 1.15 and acquisitions-related tailwind of approximately 100 basis points. Organic Revenue growth of approximately 5.0% – 7.0% (previously 5.5% – 7.5%); includes increased Nuclear Power end-market expected growth which is more than offset by reductions to Labs & Research and Dosimetry end-markets expectations. Adjusted EBITDA of approximately $223 million – $233 million (previously $215 million - $230 million); Adjusted EBITDA margin of approximately 24.0% – 25.0% (previously 24.0% – 25.5%). Adjusted Free Cash Flow of approximately $95 million – $115 million (previously $85 million - $110 million); Adjusted Free Cash Flow Conversion of approximately 43% – 49% of Adjusted EBITDA (previously 39% – 48%). Adjusted EPS of approximately $0.48 – $0.52 per share (previously $0.45 – $0.50 per share). Additional modeling and guidance assumptions are included on slide 20 in the earnings presentation on the Company's investor relations page. The Company's guidance contains forward-looking statements and actual results may differ materially as a result of known and unknown uncertainties and risks, including those set forth below under the heading 'Forward-Looking Statements.' In addition, forward-looking non-GAAP financial measures are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in projecting and quantifying the various adjusting items necessary for such reconciliations, such as stock-based compensation expense, amortization and depreciation expense, merger and acquisition activity and purchase accounting adjustments, that have not yet occurred, are out of Mirion's control, or cannot be reasonably predicted. Accordingly, reconciliations of our guidance for organic revenue growth, adjusted EBITDA, adjusted EBITDA margin, adjusted EPS, adjusted free cash flow and adjusted free cash flow conversion are not available without unreasonable effort. Conference Call Mirion will host a conference call tomorrow, August 1, 2025 at 10:00 a.m. ET to discuss its financial results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at A telephonic replay will be available shortly after the conclusion of the call and until August 15, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671, and enter access code 13754545. An archived replay of the call and an accompanying presentation will also be available on the Investors section of the Mirion website at Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Words such as 'anticipate', 'believe', 'continue', 'could', 'estimate', 'expect', 'hope', 'intend', 'may', 'might', 'plan', 'possible', 'potential', 'predict', 'project', 'should', 'strive', 'seeks', 'plans', 'would', 'will', 'understand' and similar words are intended to identify forward looking statements, but the absence of these words does not mean that a statement is not forward looking. These forward-looking statements include but are not limited to, statements regarding our future operating results, financial position and guidance, our backlog and order potential, our business strategy and plans, our objectives for future operations, macroeconomic trends, including the impact of tariffs and global trade relations, trends in cancer care, nuclear power and small modular reactor, foreign exchange, interest rate and inflation expectations and any future mergers, acquisitions, divestitures and strategic investments, including the completion and integration of previously completed transactions. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including changes in domestic and foreign business, market, economic, financial, political and legal conditions, including related to matters affecting Russia, the relationship between the United States and China, conflict in the Middle East, tariffs or other trade and supply chain disruptions, and risks of slowing economic growth or economic recession in the United States and globally; developments in the government budgets (defense and non-defense) in the United States and other countries, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, delays in the government budget process, a U.S. government shutdown or the U.S. government's failure to raise the debt ceiling; risks related to the public's perception of nuclear radiation and nuclear technologies; risks related to the continued growth of our end markets; our ability to win new customers and retain existing customers; our ability to realize sales expected from our backlog of orders and contracts; risks related to governmental contracts; our ability to mitigate risks associated with long-term fixed price contracts, including risks related to inflation; risks related to information technology system failures or other disruptions or cybersecurity, data security or other security threats; risks related to the implementation and enhancement of information systems; our ability to manage our supply chain or difficulties with third-party manufacturers; risks related to competition; our ability to manage disruptions of, or changes in, our independent sales representatives, distributors and original equipment manufacturers; our ability to realize the expected benefit from strategic transactions, such as acquisitions, divestitures, investments and partnerships, including any synergies, or internal restructuring and improvement efforts; our ability to issue debt, equity or equity-linked securities in the future; risks related to changes in tax law and ongoing tax audits; risks related to future legislation and regulation both in the United States and abroad; risks related to the costs or liabilities associated with product liability claims; risks related to the uncertainty of legal claims, litigation, arbitration and similar proceedings; our ability to attract, train and retain key members of our leadership team and other qualified personnel; risks related to the adequacy of our insurance coverage; risks related to the global scope of our operations, including operations in international and emerging markets; risks related to our exposure to fluctuations in foreign currency exchange rates, interest rates and inflation, including the impact on our debt service costs; our ability to comply with various laws and regulations and the costs associated with legal compliance; risks related to the outcome of any litigation, government and regulatory proceedings, investigations and inquiries; risks related to our ability to protect or enforce our proprietary rights on which our business depends or third-party intellectual property infringement claims; liabilities associated with environmental, health and safety matters; our ability to predict our future operational results; and the effects of health epidemics, pandemics and similar outbreaks may have on our business, results of operations or financial condition. Further information on risks, uncertainties and other factors that could affect our financial results are included in the filings we make with the United States Securities and Exchange Commission (the 'SEC') from time to time, including our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and other periodic reports filed or to be filed with the SEC. You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. Use of Non-GAAP Financial Information In addition to our results determined in accordance with GAAP, we believe that the presentation of non-GAAP financial information provides important supplemental information to management and investors regarding financial and business trends relating to our financial condition and results of operations. For further information regarding these non-GAAP measures, including the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, please refer to the financial tables below, as well as the 'Reconciliation of Non-GAAP Financial Measures' section of this press release. Non-GAAP financial information is not a substitute for GAAP financial information and undue reliance should not be placed on such non-GAAP financial information. In addition, similarly titled items used by other companies may not be comparable due to variations in how they are calculated and how terms are defined. Channels for Disclosure of Information Mirion intends to announce material information to the public through the Mirion Investor Relations website SEC filings, press releases, public conference calls and public webcasts. Mirion uses these channels, as well as social media, to communicate with its investors, customers, and the public about the company, its offerings, and other issues. It is possible that the information Mirion posts on social media could be deemed to be material information. As such, Mirion encourages investors, the media, and others to follow the channels listed above, including the social media channels listed on Mirion's investor relations website, and to review the information disclosed through such channels. Any updates to the list of disclosure channels through which Mirion will announce information will be posted on the investor relations page on Mirion's website. About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 262.6 $ 175.2 Restricted cash 0.3 0.3 Accounts receivable, net of allowance for doubtful accounts 142.2 177.7 Costs in excess of billings on uncompleted contracts 91.6 67.0 Inventories 145.1 133.2 Prepaid expenses and other current assets 51.4 41.3 Total current assets 693.2 594.7 Property, plant, and equipment, net 153.1 146.3 Operating lease right-of-use assets 29.8 30.3 Goodwill 1,470.7 1,426.2 Intangible assets, net 377.2 411.6 Restricted cash 0.1 0.1 Other assets 13.7 26.8 Total assets $ 2,737.8 $ 2,636.0 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 45.6 $ 56.5 Deferred contract revenue 88.9 96.6 Debt, current 0.4 1.2 Operating lease liability, current 6.7 6.4 Derivative liabilities, current 39.8 3.4 Accrued expenses and other current liabilities 91.0 99.3 Total current liabilities 272.4 263.4 Debt, non-current 444.5 685.2 Convertible debt 387.9 — Operating lease liability, non-current 25.6 27.1 Deferred income taxes, non-current 53.6 61.1 Other liabilities 40.2 40.1 Total liabilities 1,224.2 1,076.9 Commitments and contingencies (Note 11) Stockholders' equity (deficit): Class A common stock; $0.0001 par value, 500,000,000 shares authorized; 224,354,723 shares issued and outstanding at June 30, 2025; 225,915,767 shares issued and outstanding at December 31, 2024 — — Class B common stock; $0.0001 par value, 100,000,000 shares authorized; 6,074,885 shares issued and outstanding at June 30, 2025; 6,504,885 shares issued and outstanding at December 31, 2024 — — Treasury stock, at cost; 3,451,745 shares at June 30, 2025 and 288,013 shares December 31, 2024 (57.2 ) (3.2 ) Additional paid-in capital 2,108.7 2,143.3 Accumulated deficit (532.9 ) (541.5 ) Accumulated other comprehensive loss (56.3 ) (93.0 ) Mirion Technologies, Inc. stockholders' equity 1,462.3 1,505.6 Noncontrolling interests 51.3 53.5 Total stockholders' equity 1,513.6 1,559.1 Total liabilities and stockholders' equity $ 2,737.8 $ 2,636.0 Expand Mirion Technologies, Inc. Condensed Consolidated Statements of Operations (Unaudited) (In millions, except per share data) Three Months Ended June 30, 2025 Three Months Ended June 30, 2024 Six Months Ended June 30, 2025 Six Months Ended June 30, 2024 Revenues: Product $ 164.2 $ 154.1 $ 312.1 $ 294.1 Service 58.7 53.0 112.8 105.6 Total revenues 222.9 207.1 — 424.9 399.7 Cost of revenues: Product 92.7 82.2 174.4 161.2 Service 27.7 27.5 51.9 54.0 Total cost of revenues 120.4 109.7 226.3 215.2 Gross profit 102.5 97.4 198.6 184.5 Operating expenses: Selling, general and administrative 82.6 87.5 161.3 171.6 Research and development 10.0 8.8 18.7 16.7 Gain on disposal of business — (1.2 ) — (1.2 ) Total operating expenses 92.6 95.1 180.0 187.1 Income (loss) from operations 9.9 2.3 18.6 (2.6 ) Other expense (income): Interest expense 11.8 15.1 24.3 30.6 Interest income (2.0 ) (2.0 ) (3.9 ) (3.7 ) Loss on debt extinguishment 5.8 — 5.8 — Foreign currency (gain) loss, net (13.5 ) 0.3 (16.3 ) 1.1 (Decrease) increase in fair value of warrant liabilities — (0.4 ) — 5.3 Other expense, net — 0.6 0.3 0.7 Income (loss) before income taxes 7.8 (11.3 ) 8.4 (36.6 ) Income tax (benefit) expense (0.7 ) 0.7 (0.5 ) 1.9 Net income (loss) 8.5 (12.0 ) 8.9 (38.5 ) Income (loss) attributable to noncontrolling interests 0.2 (0.3 ) 0.3 (1.0 ) Net income (loss) attributable to Mirion Technologies, Inc. $ 8.3 $ (11.7 ) $ 8.6 $ (37.5 ) Earnings (loss) per common share attributable to Mirion Technologies, Inc.: Basic $ 0.04 $ (0.06 ) $ 0.04 $ (0.19 ) Diluted $ 0.03 $ (0.06 ) $ 0.04 $ (0.19 ) Weighted average common shares outstanding: Basic 225.026 202.197 225.339 200.963 Diluted 243.058 202.197 243.594 200.963 Expand Mirion Technologies, Inc. Consolidated Statements of Cash Flows (Unaudited) (In millions) Six Months Ended June 30, 2025 Six Months Ended June 30, 2024 OPERATING ACTIVITIES: Net income (loss) $ 8.9 $ (38.5 ) Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization expense 67.5 77.2 Stock-based compensation expense 6.7 7.6 Loss on debt extinguishment 5.8 — Amortization of debt issuance costs 1.8 1.6 Provision for doubtful accounts 1.6 1.2 Inventory obsolescence write down 0.9 1.9 Change in deferred income taxes (7.9 ) (14.4 ) Loss on disposal of property, plant and equipment — 0.6 (Gain) loss on foreign currency transactions (16.3 ) 1.1 Increase in fair values of warrant liabilities — 5.3 (Gain) loss on disposal of business — (1.2 ) Other 1.0 1.4 Changes in operating assets and liabilities: Accounts receivable 39.2 26.4 Costs in excess of billings on uncompleted contracts (4.6 ) (20.2 ) Inventories (4.5 ) (8.5 ) Prepaid expenses and other current assets (10.8 ) 3.7 Accounts payable (14.1 ) (7.4 ) Accrued expenses and other current liabilities (14.9 ) (5.8 ) Deferred contract revenue and liabilities (10.8 ) (9.5 ) Other assets 2.0 (0.5 ) Other liabilities (3.5 ) (0.8 ) Net cash provided by operating activities 48.0 21.2 INVESTING ACTIVITIES: Acquisitions of businesses, net of cash and cash equivalents acquired — (1.0 ) Proceeds from business disposal — 1.2 Purchases of property, plant, and equipment and badges (17.3 ) (23.9 ) Proceeds from net investment hedge derivative contracts 1.6 1.9 Net cash used in investing activities (15.7 ) (21.8 ) FINANCING ACTIVITIES: Stock repurchased to satisfy tax withholding for vesting restricted stock units (5.2 ) (1.0 ) Purchases of stock for treasury (49.6 ) — Proceeds from issuance of convertible senior notes, net of issuance costs 388.5 — Purchase of capped calls related to convertible senior notes (44.6 ) — Principal repayments (244.6 ) — Financing costs (3.1 ) (1.3 ) Proceeds from cash flow hedge derivative contracts 0.2 0.6 Other financing (0.4 ) (1.1 ) Net cash provided by (used in) financing activities 41.2 (2.8 ) Effect of exchange rate changes on cash, cash equivalents, and restricted cash 13.9 (3.3 ) Net increase (decrease) in cash, cash equivalents, and restricted cash 87.4 (6.7 ) Cash, cash equivalents, and restricted cash at beginning of period 175.6 130.5 Cash, cash equivalents, and restricted cash at end of period $ 263.0 $ 123.8 Expand Share Count 224,354,723 shares of Class A common stock were outstanding as of June 30, 2025. This excludes (1) 6,074,885 shares of Class B common stock outstanding as of June 30, 2025, (2) 1,128,338 million shares of Class A common stock underlying restricted stock units and 1,387,371 million shares of Class A common stock underlying performance stock units; and (3) any other shares issuable from future equity awards under our 2021 Omnibus Incentive Plan, which had 39,880,849 shares reserved (subject to annual automatic increases) as of June 30, 2025. The 6,074,885 shares of Class B common stock are paired on a one-for-one basis with shares of Class B common stock of Mirion Intermediate Co., Inc. (the "paired interests"). Holders of the paired interests have the right to have their interests redeemed for, at the option of Mirion, shares of Class A common stock on a one-for-one basis or cash based on a trailing stock price average. All share data is as of June 30, 2025, unless otherwise noted. Reconciliation of Non-GAAP Financial Measures In addition to our results determined in accordance with GAAP, we believe the following non-GAAP measures are useful in evaluating our operating performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures and not rely on any single financial measure to evaluate our business. Organic revenue is defined as Revenue excluding the impact of foreign exchange rates as well as mergers, acquisitions and divestitures in the period. Adjusted EBITDA is defined as net income before interest expense, income tax expense, depreciation and amortization adjusted to remove the impact of foreign currency gains and losses, amortization of acquired intangible assets, changes in the fair value of warrants, certain non-operating expenses (restructuring and costs to achieve operational synergies, merger, acquisition and divestiture expenses and IT project implementation expenses), stock-based compensation expense, debt extinguishment and income tax impacts of these adjustments. Adjusted EBITDA margin is defined as Adjusted EBITDA divided by Revenue. Adjusted net income is defined as GAAP net income adjusted for foreign currency gains and losses, amortization of acquired intangible assets, changes in the fair value of warrants, certain non-operating expenses (restructuring and costs to achieve operational synergies, merger, acquisition and divestiture expenses and IT project implementation expenses), stock-based compensation expense, debt extinguishment and income tax impacts of these adjustments. Adjusted EPS is defined as adjusted net income divided by weighted average common shares outstanding — basic and diluted. Adjusted free cash flow is defined as free cash flow adjusted to include the impact of cash used to fund non-operating expenses. We believe that the inclusion of supplementary adjustments to free cash flow applied in presenting adjusted free cash flow is appropriate to provide additional information to investors about our cash flows that management utilizes on an ongoing basis to assess our ability to generate cash for use in acquisitions and other investing and financing activities. Adjusted free cash flow conversion is defined as adjusted free cash flow divided by adjusted EBITDA. Free cash flow is defined as U.S. GAAP net cash provided by operating activities adjusted to include the impact of purchases of property, plant, and equipment, purchases of badges and proceeds from derivative contracts. Net leverage is defined as Net Debt (debt minus cash and cash equivalents) divided by Adjusted EBITDA plus contributions to Adjusted EBITDA if acquisitions made during the applicable period had been made before the start of the applicable period. Operating Metrics Order and orders growth are defined as the amount of revenue earned in a given period and estimated to be earned in future periods from contracts entered into in a given period as compared with such amount for a prior period. Foreign exchange rates are based on the applicable rates as reported for the time period. The following tables present reconciliations of certain non-GAAP financial measures for the applicable periods. Mirion Technologies, Inc. Reconciliation of Adjusted Earnings per Share (In millions, except per share values) Three Months Ended June 30, 2025 2024 Net income (loss) attributable to Mirion Technologies, Inc. $ 8.3 $ (11.7 ) Gain (loss) attributable to non-controlling interests 0.2 (0.3 ) GAAP net income (loss) $ 8.5 $ (12.0 ) Foreign currency loss (gain), net (13.5 ) 0.3 Amortization of acquired intangibles 25.2 31.0 Stock-based compensation 3.4 4.0 Change in fair value of warrant liabilities — (0.4 ) Loss on debt extinguishment and other related costs 6.3 — Non-operating expenses 3.5 4.6 Tax impact of adjustments above (7.2 ) (8.1 ) Adjusted net income $ 26.2 $ 19.4 Weighted average common shares outstanding — basic 225.026 202.197 Dilutive potential common shares — stock-based awards 0.722 0.808 Dilutive potential common shares — convertible debt 17.310 — Adjusted weighted average common shares — diluted 243.058 203.005 GAAP earnings (loss) per share — basic $ 0.04 $ (0.06 ) Adjusted earnings per share $ 0.11 $ 0.10 Expand
Business Wire
31-07-2025
- Business
- Business Wire
Mirion Acquires Certrec, a Leader in Regulatory Compliance and Advanced Digital Applications for the Nuclear Industry
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced the acquisition of Certrec, a leading supplier of regulatory compliance and digital integration solutions for the energy industry. Operating out of Fort Worth, TX, Certrec solutions help ensure a stable and reliable bulk electric supply. Since 1988, Certrec's innovation and industry expertise has helped hundreds of power-generating facilities reduce risk and manage regulatory compliance with the Nuclear Regulatory Commission (NRC) and North American Electric Reliability Corporation (NERC). Areas of expertise include licensing, regulatory affairs, compliance, training, and operations, in support of nuclear, fossil, solar, wind facilities, and other types of generating assets. Today, every US nuclear reactor facility employs Certrec solutions, and more than 80 entities in the U.S., Canada and Mexico rely upon Certrec NERC compliance services to decrease regulatory and reputational risk. 'I am delighted to welcome Certrec to the Mirion family,' said Thomas Logan, Mirion's Chairman and Chief Executive Officer. 'The Certrec team brings deep industry relationships and significant software and services capabilities to Mirion that will be pivotal in expanding our offerings in the nuclear power market and further strengthen the development of our digital ecosystem.' Certrec, joining the Mirion Nuclear & Safety group, is ISO/IEC 27001:2022 certified and has successfully completed annual SOC 2 Type 2 examinations. The cash purchase price of $81 million plus additional equity incentives granted reflects an acquisition multiple of 16.9x EV/'25E EBITDA for a high-recurring revenue software and services business. For more information about Certrec, please visit About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at
Business Wire
21-07-2025
- Business
- Business Wire
Mirion Technologies Unveils the Vital Platform, a Digital Ecosystem Powering Integrated Operations for Nuclear Energy and Beyond
ATLANTA--(BUSINESS WIRE)-- Mirion Technologies, a leading provider of advanced radiation safety solutions, announced the launch of the Vital Platform. This software offers a single, unified system for accessing data across nuclear power sites to work more efficiently, enhance worker safety, and solve operational challenges faster. The launch includes the platform's first application, Vital Supervision, designed to enhance radiological instrument data visibility, improve response times, and simplify oversight across critical radiological systems. The Vital Platform was developed to meet nuclear industry demands for a more connected and efficient way to manage radiological instrument data. Rather than relying on fragmented systems or manual processes, Vital enables teams to work within one streamlined environment prioritizing speed, security, and long-term adaptability. 'This digital offering represents a significant leap forward in radiation safety and management and is driven by demand for a comprehensive, transformative solution tailor-made for critical environments,' said Thomas Logan, CEO of Mirion. 'Vital is a critical enabler of advancements taking place at Mirion in our digital and physical portfolio of solutions for nuclear power and related fields.' Key benefits to customers include: Data Integration and Real Time Monitoring: Real-time tracking across systems enables faster, proactive responses. Regulatory Compliance and Reporting: Automated, standardized reporting simplifies regulatory alignment. Operational Efficiency and Cost Reduction: Streamlined workflows cut time, reduce errors, and lower costs. Security and Risk Mitigation: Access controls and cybersecurity safeguard sensitive data. Facilitating Advanced Analytics: Detailed data helps predict risks and improve decision-making. Scalability and Future Proofing: Modular design supports growth and adapts to change. Supervision: The First Vital Platform Application Vital Supervision is the first in a series of applications to be built on the Vital Platform, with the aim to unify the capabilities of siloed, standalone software into one platform. This application simplifies the collection and analysis of data from a wide variety of radiological instruments. Real-time, at-a-glance access to alarms, measurement data and instrument health significantly enhances the monitoring and management of critical equipment. The Vital Platform and Vital Supervision application will be showcased at two key upcoming industry events. A webinar presentation facilitated through Nuclear Engineering International (July 23) and Mirion's annual users' conference Mirion Connect (July 28-August 1) will offer opportunities to explore platform capabilities in depth. About Mirion Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at
Yahoo
27-06-2025
- Business
- Yahoo
Specialized Technology Stocks Q1 Teardown: Mirion (NYSE:MIR) Vs The Rest
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let's take a look at how specialized technology stocks fared in Q1, starting with Mirion (NYSE:MIR). Companies in this sector, especially if they invest wisely, could see demand tailwinds as the world moves towards more IoT (Internet of Things), automation, and analytics. Enterprises across most industries will balk at taking these journeys solo and will enlist companies with expertise and scale in these areas. However, headwinds could include rising competition from larger technology firms, as digitization lowers barriers to entry in the space. Additionally, companies in the space will likely face evolving regulatory scrutiny over data privacy, particularly for surveillance and security technologies. This could make companies have to continually pivot and invest. The 8 specialized technology stocks we track reported a strong Q1. As a group, revenues beat analysts' consensus estimates by 1.3% while next quarter's revenue guidance was in line. Luckily, specialized technology stocks have performed well with share prices up 25.5% on average since the latest earnings results. With its technology protecting workers in over 130 countries and equipment used in 80% of cancer centers worldwide, Mirion Technologies (NYSE:MIR) provides radiation detection, measurement, and monitoring solutions for medical, nuclear energy, defense, and scientific research applications. Mirion reported revenues of $202 million, up 4.9% year on year. This print exceeded analysts' expectations by 0.6%. Overall, it was an exceptional quarter for the company with a solid beat of analysts' EPS estimates and an impressive beat of analysts' full-year EPS guidance estimates. 'We delivered a strong start to the year, with year-over-year revenue growth and adjusted free cash flow generation,' commented Mirion's Chairman and Chief Executive Officer Thomas Logan. Interestingly, the stock is up 38.4% since reporting and currently trades at $21.55. Is now the time to buy Mirion? Access our full analysis of the earnings results here, it's free. Originally spun off from networking equipment maker Netgear in 2018, Arlo Technologies (NYSE:ARLO) provides cloud-based smart security devices and subscription services that help consumers and businesses monitor and protect their homes, properties, and loved ones. Arlo Technologies reported revenues of $119.1 million, down 4.1% year on year, outperforming analysts' expectations by 0.6%. The business had an exceptional quarter with an impressive beat of analysts' EPS estimates. The market seems happy with the results as the stock is up 62% since reporting. It currently trades at $17.27. Is now the time to buy Arlo Technologies? Access our full analysis of the earnings results here, it's free. Taking its name from the black and white stripes of barcodes, Zebra Technologies (NASDAQ:ZBRA) provides barcode scanners, mobile computers, RFID systems, and other data capture technologies that help businesses track assets and optimize operations. Zebra reported revenues of $1.31 billion, up 11.3% year on year, exceeding analysts' expectations by 1.4%. Still, it was a slower quarter as it posted a significant miss of analysts' EPS guidance for next quarter estimates and revenue guidance for next quarter meeting analysts' expectations. Interestingly, the stock is up 27.1% since the results and currently trades at $309.50. Read our full analysis of Zebra's results here. Protecting everything from schools to government facilities since 1969, Napco Security Technologies (NASDAQ:NSSC) manufactures electronic security devices, access control systems, and communication services for intrusion and fire alarm systems. Napco reported revenues of $43.96 million, down 10.8% year on year. This result beat analysts' expectations by 1.9%. Overall, it was an exceptional quarter as it also logged a solid beat of analysts' EPS estimates. Napco had the slowest revenue growth among its peers. The stock is up 25.5% since reporting and currently trades at $29.85. Read our full, actionable report on Napco here, it's free. Born from a corporate transformation completed in 2023, Crane NXT (NYSE:CXT) provides specialized technology solutions for payment processing, banknote security, and authentication systems for financial institutions and businesses. Crane NXT reported revenues of $330.3 million, up 5.3% year on year. This number topped analysts' expectations by 3.9%. Overall, it was a very strong quarter as it also produced a solid beat of analysts' organic revenue estimates and a decent beat of analysts' EPS estimates. Crane NXT achieved the biggest analyst estimates beat among its peers. The stock is up 16.6% since reporting and currently trades at $55.58. Read our full, actionable report on Crane NXT here, it's free. In response to the Fed's rate hikes in 2022 and 2023, inflation has been gradually trending down from its post-pandemic peak, trending closer to the Fed's 2% target. Despite higher borrowing costs, the economy has avoided flashing recessionary signals. This is the much-desired soft landing that many investors hoped for. The recent rate cuts (0.5% in September and 0.25% in November 2024) have bolstered the stock market, making 2024 a strong year for equities. Donald Trump's presidential win in November sparked additional market gains, sending indices to record highs in the days following his victory. However, debates continue over possible tariffs and corporate tax adjustments, raising questions about economic stability in 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-03-2025
- Business
- Yahoo
Mirion Technologies Joins Influential Nuclear Energy Organizations to Further Bolster Nuclear Initiatives
Mirion joins the Nuclear Energy Institute, enhances membership with the American Nuclear Society as a Trustees of Nuclear partner. ATLANTA, March 13, 2025--(BUSINESS WIRE)--Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced that it has joined the Nuclear Energy Institute (NEI) and the American Nuclear Society's (ANS) Trustees of Nuclear program. Membership in the two preeminent nuclear industry and professional organizations in the United States provides Mirion Technologies with an enhanced platform to engage with industry leaders and policymakers, as well as share industry expertise, on issues of importance to the nuclear sector. NEI is the policy organization of the nuclear energy industry in the United States, representing the interests of the industry before Congress, the administration, and state and local governments. With its NEI membership, Mirion will participate in policy discussions that shape the nuclear industry and advocate for policies that support the growth of nuclear energy for the greater good of humanity. ANS is the premier international professional organization of engineers, scientists, technologists, teachers, and healthcare providers devoted to the peaceful applications of nuclear science and technology. As part of its enhanced membership in ANS, Mirion will become an ANS Trustee of Nuclear and serve on its leadership council. "As one of the only companies uniquely present across the full span of the nuclear landscape, we have an important role to play in the Nuclear Renaissance. We are thrilled to build upon our bonds with the Nuclear Energy Institute and the American Nuclear Society," said Mirion CEO Thomas Logan. "These memberships underscore our commitment to advancing the nuclear industry and continued collaboration with leading experts and organizations. We look forward to contributing to the innovative solutions and best practices that will shape the future of nuclear energy." About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at View source version on Contacts For investor inquiries: Eric Linnir@ For media inquiries: Erin Schesnymedia@
